MX355048B - Metodo de separacion para anticuerpos fucosilados. - Google Patents

Metodo de separacion para anticuerpos fucosilados.

Info

Publication number
MX355048B
MX355048B MX2014004604A MX2014004604A MX355048B MX 355048 B MX355048 B MX 355048B MX 2014004604 A MX2014004604 A MX 2014004604A MX 2014004604 A MX2014004604 A MX 2014004604A MX 355048 B MX355048 B MX 355048B
Authority
MX
Mexico
Prior art keywords
antibodies
separation method
fucosylated antibodies
separation
fucosylation
Prior art date
Application number
MX2014004604A
Other languages
English (en)
Other versions
MX2014004604A (es
Inventor
Umana Pablo
Freimoser-Grundschober Anne
Jaeger Christiane
Sondermann Peter
Original Assignee
Roche Glycart Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Glycart Ag filed Critical Roche Glycart Ag
Publication of MX2014004604A publication Critical patent/MX2014004604A/es
Publication of MX355048B publication Critical patent/MX355048B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a un método para la separación de anticuerpos, específicamente anticuerpos que tienen diferentes grados de fucosilación. El método se basa en la afinidad de unión de los anticuerpos a los receptores Fc. La invención se refiere adicionalmente al uso de receptores Fc para la separación de anticuerpos que tienen diferentes grados de fucosilación.
MX2014004604A 2011-10-19 2012-10-16 Metodo de separacion para anticuerpos fucosilados. MX355048B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11185798 2011-10-19
PCT/EP2012/070439 WO2013057078A1 (en) 2011-10-19 2012-10-16 Separation method for fucosylated antibodies

Publications (2)

Publication Number Publication Date
MX2014004604A MX2014004604A (es) 2014-05-27
MX355048B true MX355048B (es) 2018-04-03

Family

ID=47019025

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004604A MX355048B (es) 2011-10-19 2012-10-16 Metodo de separacion para anticuerpos fucosilados.

Country Status (12)

Country Link
US (2) US9994610B2 (es)
EP (1) EP2768845B1 (es)
JP (2) JP6356605B2 (es)
KR (1) KR20140077178A (es)
CN (2) CN103890002A (es)
BR (1) BR112014009178A2 (es)
CA (1) CA2851053A1 (es)
ES (1) ES2619677T3 (es)
HK (2) HK1258766A1 (es)
MX (1) MX355048B (es)
RU (1) RU2650873C2 (es)
WO (1) WO2013057078A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
SG174804A1 (es) 2006-09-13 2011-10-28 Abbott Lab
SG10201702951RA (en) 2008-10-20 2017-06-29 Abbvie Inc Viral inactivation during purification of antibodies
AU2009347206C1 (en) 2008-10-20 2016-12-08 Abbvie Inc. Isolation and purification of antibodies using Protein A affinity chromatography
CN103827134A (zh) 2011-07-20 2014-05-28 泽普泰恩股份有限公司 多肽分离方法
JP6451119B2 (ja) * 2014-07-17 2019-01-16 東ソー株式会社 抗体依存性細胞傷害活性の強さに基づき抗体を分離する方法
US20180319838A1 (en) * 2015-11-04 2018-11-08 Biogen Ma Inc. Conjugation methods for modifying or immobilizing proteins
SG11202003765RA (en) * 2017-04-06 2020-05-28 Flodesign Sonics Inc Acoustic perfusion devices
EP3993887B1 (en) * 2019-07-03 2023-07-26 Merck Patent GmbH Glycoform purification
US20230236194A1 (en) * 2019-07-12 2023-07-27 National University Corporation Hokkaido University Development of blood fibrosis marker for non-alcoholic steatohepatitis
GB202204016D0 (en) * 2022-03-22 2022-05-04 Ucl Business Plc Affinity chromatography ligands for antibody glycovariant separation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007089A1 (en) * 1987-03-18 1988-09-22 Medical Research Council Altered antibodies
US6410690B1 (en) * 1995-06-07 2002-06-25 Medarex, Inc. Therapeutic compounds comprised of anti-Fc receptor antibodies
DK2180007T4 (da) 1998-04-20 2017-11-27 Roche Glycart Ag Glycosyleringsteknik for antistoffer til forbedring af antistofafhængig cellecytotoxicitet
EP1006183A1 (en) * 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors
NZ592087A (en) 2001-08-03 2012-11-30 Roche Glycart Ag Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
KR101292000B1 (ko) 2003-01-22 2013-08-01 로슈 글리카트 아게 융합 구성체와 Ｆｃ 수용체 결합 친화도 및 이펙터 기능이증가된 항체를 생성하기 위한 이의 용도
CN101098890B (zh) * 2004-11-12 2012-07-18 赞科股份有限公司 对FcRn的结合被改变的Fc变体
US7699979B2 (en) * 2005-01-07 2010-04-20 Board Of Trustees Of The University Of Arkansas Separation system and efficient capture of contaminants using magnetic nanoparticles
KR101247836B1 (ko) * 2005-06-17 2013-03-28 와이어쓰 엘엘씨 항 ａ 베타 항체의 정제 방법
WO2010048313A2 (en) * 2008-10-22 2010-04-29 Biogen Idec Ma Inc. Recombinant fcrn and variants thereof for purification of fc-containing fusion proteins
WO2011039150A1 (en) 2009-10-02 2011-04-07 Roche Glycart Ag A-fucosylation detection in antibodies
CN103827134A (zh) * 2011-07-20 2014-05-28 泽普泰恩股份有限公司 多肽分离方法

Also Published As

Publication number Publication date
US9994610B2 (en) 2018-06-12
EP2768845B1 (en) 2017-01-18
US20140255399A1 (en) 2014-09-11
CN108314729A (zh) 2018-07-24
JP2014530829A (ja) 2014-11-20
WO2013057078A1 (en) 2013-04-25
EP2768845A1 (en) 2014-08-27
RU2014118552A (ru) 2015-11-27
JP2018184406A (ja) 2018-11-22
RU2650873C2 (ru) 2018-04-17
HK1258766A1 (zh) 2019-11-22
HK1199272A1 (en) 2015-06-26
MX2014004604A (es) 2014-05-27
US20180265544A1 (en) 2018-09-20
CA2851053A1 (en) 2013-04-25
JP6356605B2 (ja) 2018-07-11
CN103890002A (zh) 2014-06-25
KR20140077178A (ko) 2014-06-23
BR112014009178A2 (pt) 2018-09-04
ES2619677T3 (es) 2017-06-26

Similar Documents

Publication Publication Date Title
MX2014004604A (es) Metodo de separacion para anticuerpos fucosilados.
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
GB201103836D0 (en) Conjugation process
IL230772A0 (en) Specific antibodies with subsequent fc
UA117801C2 (uk) Лікування неврологічного порушення за допомогою антитіла, яке має низьку афінність до рецептора гематоенцефалічного бар'єру
MX342034B (es) Proteinas monovalentes que se unen a antigenos.
HK1199837A1 (en) Humanized antibodies to inkt inkt
WO2012093809A3 (en) New bicyclic compound for modulating g protein-coupled receptors
IL236523B (en) Methods for producing antibody molecules with intra-target cross-sexual reactivity
MX343659B (es) Proteínas de unión receptoras fc.
IL231404A0 (en) Antibody against affinity conjugate
MX2015003541A (es) Metodos para identificar los anticuerpos con inmunogenia reducida.
HK1201920A1 (zh) 用於檢測多特異性結合物的游離結合搭檔的方法
MX2014002996A (es) Anticuerpos anti - egfr/anti - igf-1r bisespecificos.
WO2013115410A3 (en) Anti-phospholipase d4 antibody
WO2012149334A3 (en) Methods and compositions for the generation and use of conformation-specific antibodies
MX352837B (es) Método para marcaje de objetivos intracelulares y extracelulares de leucocitos.
WO2012137180A3 (en) Biomarkers of immunotherapy efficacy
EP2997001A4 (en) Methods for separating hydrocarbon gases
EP2686016A4 (en) ANTIBODIES FOR THE DETECTION OF THE N-DOMAIN OF MIDKIN
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
WO2013092672A3 (en) Method for recombinant production of labyrinthopeptins and functional derivatives thereof
WO2013072938A3 (en) Process for the preparation of roflumilast
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
WO2013050928A3 (en) An apparatus configured to have multiple user interfaces and method

Legal Events

Date Code Title Description
FG Grant or registration